Abstract
After more than 100 years since the first adjuvant for a cancer vaccine was described and more than a decade since the first tumor antigen has been molecularly cloned, it seems possible that cancer vaccines might be integrated into the standard care of cancer patients. Exciting new technologies concerning tumor antigen discovery, vaccine delivery and formulation define the basis for enormous efforts in academia as well as in the pharmaceutical and biotech industry. With the unveiling of the human genome additional targets will emerge that could further enhance vaccine efficacy, specificity and clinical applicability. Most likely therefore, tumor antigen targets which are widely expressed in cancer will be of advantage over patient-oriented approaches due to their favorable cost-to-benefit ratio. Some widely expressed candidate tumor antigens and methods to discover additional widely expressed tumor antigens are discussed here. While the armamentarium of potential tools to cancer vaccine development seems to be endless, only those that are scientifically sound yet economically reasonable will - in the end - have a chance to become clinically useful cancer vaccines.
Keywords: genomics, cancer vaccine development, biochemical approaches, the spectrum, pre-existing immunity, reverse immunology, murine models
Current Pharmaceutical Design
Title: Influence of Genomics on Cancer Vaccine Development - from Guess to Prediction
Volume: 8 Issue: 19
Author(s): Joachim L. Schultze and Heribert Bohlen
Affiliation:
Keywords: genomics, cancer vaccine development, biochemical approaches, the spectrum, pre-existing immunity, reverse immunology, murine models
Abstract: After more than 100 years since the first adjuvant for a cancer vaccine was described and more than a decade since the first tumor antigen has been molecularly cloned, it seems possible that cancer vaccines might be integrated into the standard care of cancer patients. Exciting new technologies concerning tumor antigen discovery, vaccine delivery and formulation define the basis for enormous efforts in academia as well as in the pharmaceutical and biotech industry. With the unveiling of the human genome additional targets will emerge that could further enhance vaccine efficacy, specificity and clinical applicability. Most likely therefore, tumor antigen targets which are widely expressed in cancer will be of advantage over patient-oriented approaches due to their favorable cost-to-benefit ratio. Some widely expressed candidate tumor antigens and methods to discover additional widely expressed tumor antigens are discussed here. While the armamentarium of potential tools to cancer vaccine development seems to be endless, only those that are scientifically sound yet economically reasonable will - in the end - have a chance to become clinically useful cancer vaccines.
Export Options
About this article
Cite this article as:
Schultze L. Joachim and Bohlen Heribert, Influence of Genomics on Cancer Vaccine Development - from Guess to Prediction, Current Pharmaceutical Design 2002; 8 (19) . https://dx.doi.org/10.2174/1381612023393990
DOI https://dx.doi.org/10.2174/1381612023393990 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Potentialities of Induced Pluripotent Stem (iPS) Cells for Treatment of Diseases
Current Molecular Medicine Marine Natural Products and Related Compounds as Anticancer Agents: an Overview of their Clinical Status
Anti-Cancer Agents in Medicinal Chemistry Conjugation of Peptides to Antisense Interleukin-6 Via Click Chemistry
Current Medicinal Chemistry Gene Therapy for Pituitary Tumors
Current Gene Therapy The Discovery of Antiangiogenic Molecules: A Historical Review
Current Pharmaceutical Design Metallothioneins and Cancer
Current Protein & Peptide Science Interactions of Iron Oxide Nanoparticles with the Immune System: Challenges and Opportunities for their Use in Nano-oncology
Current Pharmaceutical Design Mucoadhesive Polymers for Delivery of Drugs to the Oral Cavity
Recent Patents on Drug Delivery & Formulation Clinical Applicability of Microarray Technology in the Diagnosis, Prognostic Stratification, Treatment and Clinical Surveillance of Cervical Adenocarcinoma
Current Pharmaceutical Design Effects of Bioactive Compounds from Carrots (Daucus carota L.), Polyacetylenes, Beta-Carotene and Lutein on Human Lymphoid Leukaemia Cells
Anti-Cancer Agents in Medicinal Chemistry Tobacco Smoking: Risk to Develop Addiction, Chronic Obstructive Pulmonary Disease, and Lung Cancer
Recent Patents on Anti-Cancer Drug Discovery The TGF-β Signaling Pathway as a Pharmacological Target in a Hepatocellular Carcinoma
Current Pharmaceutical Design Histone Deacetylase (HDAC) Inhibitors as Potential Drugs to Target Memory and Adult Hippocampal Neurogenesis
Current Psychopharmacology Proteasome Structure, Function, and Lessons Learned from Beta-Lactone Inhibitors
Current Topics in Medicinal Chemistry A Century of Thioxanthones: Through Synthesis and Biological Applications
Current Medicinal Chemistry Recent Developments in Taxane Drug Delivery
Current Drug Delivery Synthesis of Marine Natural Products with Antimalarial Activity
Mini-Reviews in Medicinal Chemistry Advancing Drug Therapy for Brain Tumours: A Current Review of the Pro-inflammatory Peptide Substance P and its Antagonists as Anti-cancer Agents
Recent Patents on CNS Drug Discovery (Discontinued) Comparative Analysis of RNAi Screening Technologies at Genome-Scale Reveals an Inherent Processing Inefficiency of the Plasmid-Based shRNA Hairpin
Combinatorial Chemistry & High Throughput Screening Dynamic Localization of Hepatocellular Transporters: Role in Biliary Excretion and Impairment in Cholestasis
Current Medicinal Chemistry